Demo Sign up Log In

R&D Expenses

$1.95B

TTM · Period ending: Jun 30, 2026 · USD

BIIB R&D Expenses

Latest reported$1.95Bperiod endingJun 30, 2026

Latest reported$1.95Bperiod endingJun 30, 2026

BIIB TTM R&D Expenses ($0.00 → $1.95B)

TTM R&D Expenses

High-resolution chart · PNG

BIIB r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Biogen R&D Expenses — Trailing twelve months (TTM) (USD)
Period ending	R&D Expenses (USD)
Jun 30, 2001	320,021,000
Mar 31, 2001	312,604,000
Dec 31, 2000	302,840,000
Sep 30, 2000	289,458,000
Jun 30, 2000	253,960,000
Mar 31, 2000	233,159,000
Dec 31, 1999	221,153,000
Sep 30, 1999	209,828,000
Jun 30, 1999	199,928,000
Mar 31, 1999	191,128,000
Dec 31, 1998	177,228,000
Sep 30, 1998	166,801,000
Jun 30, 1998	154,701,000
Mar 31, 1998	144,601,000
Dec 31, 1997	145,401,000
Sep 30, 1997	155,084,000
Jun 30, 1997	148,484,000
Mar 31, 1997	145,784,000
Dec 31, 1996	132,384,000
Sep 30, 1996	107,448,000
Jun 30, 1996	99,548,000
Mar 31, 1996	91,548,000
Dec 31, 1995	87,448,000
Sep 30, 1995	83,013,000
Jun 30, 1995	83,313,000
Mar 31, 1995	88,313,000
Dec 31, 1994	91,213,000
Sep 30, 1994	72,400,000
Jun 30, 1994	49,600,000
Mar 31, 1994	23,300,000
Dec 31, 1993	0
Sep 30, 1993	0
Jun 30, 1993	0
Mar 31, 1993	0
Dec 31, 1992	0
Sep 30, 1992	0
Jun 30, 1992	0
Mar 31, 1992	0
Dec 31, 1991	0
Sep 30, 1991	0
Jun 30, 1991	0
Mar 31, 1991	0
Dec 31, 1990	0
Sep 30, 1990	0
Jun 30, 1990	0
Mar 31, 1990	0
Dec 31, 1989	0
Sep 30, 1989	0
Jun 30, 1989	0
Mar 31, 1989	0
Dec 31, 1988	0
Sep 30, 1988	0
Jun 30, 1988	0
Mar 31, 1988	0
Dec 31, 1987	0
Sep 30, 1987	0
Jun 30, 1987	0
Mar 31, 1987	0
Dec 31, 1986	0
Sep 30, 1986	0
Jun 30, 1986	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.